Prime Medicine, Inc. (PRME)

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein–a hybrid composed of a Cas protein and a reverse transcriptase enzyme–with a specialized pegRNA molecule.